Skip to main content
Clinical Trials/TCTR20240321005
TCTR20240321005Not yet recruitingPhase 3

Effects of synbiotic supplementation on intestinal microbiota , antioxidant status and short chain fatty acids among pediatric obesity : A Randomized clinical trial

Faculty of Medicine, Chulalongkorn University0 sites60 target enrollmentStarted: March 21, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
7 Years to 18 Years (—)
Sex
All

Inclusion Criteria

  • 1. Age 7 to 18 years
  • 2. BMI > median + 2SDs (WHO reference)
  • 3. No history of pre-/pro-/ synbiotic supplementation or antibiotics use at least 4 weeks prior to participation.

Exclusion Criteria

  • 1. Cow's milk protein allergy
  • 2. Syndromic obesity
  • 3. Endocrine causes of obesity (e.g. hypothyroidism, growth hormone deficiency)
  • 4. Use of drugs that influence apetite or body weight (e.g. corticosteroids)
  • 5. Attending other concurrent weight reduction programs

Investigators

Similar Trials